Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhiyu Anshen granules vs fluoxetine for depression (liver qi stagnation transforming into fire)
CTR20132704Phase 3Completed
- Sponsor
- Tianjin Xuanhong Pharmaceutical Technology
- Start
- Jul 2014
- Countries
- 1
01
Overview
A Phase 3 trial of Zhiyu Anshen in major depressive disorder (MDD), major depressive episode (MDE), sponsored by Tianjin Xuanhong Pharmaceutical Technology. Started Jul 2014; status: completed.
02
Drugs
Zhiyu Anshen
03
Conditions
major depressive disorder (MDD)major depressive episode (MDE)
Beyond the preview
Go deeper on CTR20132704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132704.